DGNOF · Diagnos Inc.
Market Cap
$43.57M
Shares
121.04M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.34
Open$0.33
Day$0.33–0.35
52W close$0.13–0.36
Avg vol 30d102K
Short int10 · 0.0% float · 1.0d
Short vol8%
DataJan 2020–Sep 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
+80.8%
Trailing year
Short interest
0.0%
Latest settlement · 1.0 days to cover
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 14.8 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+57%
above
Price vs 50-day avg
+30%
above
RSI (14)
58
neutral
MACD trend
Negative
52-week position
89%
near high
Momentum
relative strength
1-month return
+20%
trailing
6-month return
+60%
trailing
YTD return
+29%
this year
Relative strength
+40%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $0 — 50d above 200d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.00% of float · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Squeeze score
37
low risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
81%
annualized · 1-yr
Max drawdown
−52%
past year
ATR
6.9%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+57%
Bullish
Price vs 50-day avg
+30%
Bullish
RSI (14)
58
Neutral
MACD trend
Negative
Bearish
52-week position
89%
Bullish
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross)
No cross
50d $0 › 200d $0 — 50d above 200d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.00% of float · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its 52-week range
Range low $0
Now $0 · 89%
Range high $0
vs 200-day avg +57%
vs 50-day avg +30%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Health Information Services — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
DGNOF
this stock
Diagnos Inc.
|
$43.57M | +29.2% | — | — | 0.0% |
|
VEEV
Veeva Systems Inc
|
$43.69B | +16.6% | +28.1% | 44.2 | 3.0% |
|
PMDIY
Pro Medicus Ltd./ADR
|
$12.54B | -28.9% | — | — | 0.0% |
|
TEM
Tempus AI, Inc.
|
$11.99B | +31.8% | +83.4% | — | 16.3% |
|
BTSG
BrightSpring Health Services, Inc.
|
$11.73B | +51.6% | +28.2% | 35.9 | 5.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionShort & Settlement
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| DGNOF | +7.3% | +19.9% | +59.9% | -4.1% | +29.2% |
| SPY | -0.3% | -0.1% | +20.1% | -0.7% | +11.7% |
| vs SPY | +7.7% | +20.1% | +39.8% | -3.4% | +17.5% |